We serve Chemical Name:2-Amino-1,3,4-thiadiazole CAS:4005-51-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Amino-1,3,4-thiadiazole
CAS.NO:4005-51-0
Synonyms:T5NN DSJ CZ;X 26;FDA 0084;Aminothiadiazole;TF 128;1,3,4-thiadiazol-2-amine;1,3,4-thiadiazol-2-ylamine;2-AMino-1;2-Amino-1,3,4-thiadiazole;EINECS 223-657-7;MFCD00003107;aminothiadazole;5-amino-1,3,4-thiadiazole
Molecular Formula:C2H3N3S
Molecular Weight:101.130
HS Code:2934999090
Physical and Chemical Properties:
Melting point:187-192 ºC
Boiling point:238.9±23.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.663
PSA:80.04000
Exact Mass:101.004768
LogP:-0.57
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:2811
Packing Group:III
Contact us for information like T5NN DSJ CZ chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-amino-1,3,4-thiadiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00003107 Use and application,X 26 technical grade,usp/ep/jp grade.
Related News: The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care. 2-Amino-1,3,4-thiadiazole manufacturer In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. 2-Amino-1,3,4-thiadiazole supplier The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care. 2-Amino-1,3,4-thiadiazole vendor Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 2-Amino-1,3,4-thiadiazole factory In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.
